Clues Pointing TO This Diagnosis

Waist circumference 37 inches — abdominal obesity above the 40-inch male threshold is a core criterion and marker of visceral adiposity and insulin resistance
Blood pressure 136/88 — meets the ≥130/85 mm Hg criterion for the syndrome
Fasting glucose 108 mg/dL — falls in the 100–125 mg/dL range, meeting the ≥100 mg/dL dysglycemia criterion and defining prediabetes
Triglycerides 240 mg/dL — well above the ≥150 mg/dL criterion, reflecting atherogenic dyslipidemia
HDL 32 mg/dL — below the <40 mg/dL male threshold, the low-HDL criterion
All five criteria present — three of five are required, and Phineas has all five, making the diagnosis unequivocal
Middle-aged, sedentary office worker with central adiposity — the classic demographic and behavioral substrate driven by underlying insulin resistance
Clustering of interrelated risk factors — these findings co-occur far more than by chance and share insulin resistance as the common driver

Why It's NOT the Similar Diseases

NOT type 2 diabetes — his fasting glucose of 108 mg/dL is in the prediabetes range (100–125), below the diabetes threshold of ≥126 mg/dL; he has impaired fasting glucose, not diabetes
NOT isolated essential hypertension — a BP of 136/88 alone would be one finding, but he also has central obesity, dyslipidemia, and dysglycemia, defining a broader syndrome
NOT primary hyperlipidemia (e.g., familial) — his lipid abnormalities cluster with obesity, hypertension, and dysglycemia rather than presenting as an isolated severe genetic dyslipidemia
NOT Cushing syndrome — no described features such as proximal weakness, striae, easy bruising, or moon facies; his picture is explained by adiposity-driven insulin resistance
NOT hypothyroidism — no fatigue, cold intolerance, weight gain, or bradycardia described; the clustering points to insulin resistance, though TSH is reasonable to check

Differential Diagnosis List

Type 2 diabetes mellitus — ruled out by fasting glucose of 108 mg/dL (prediabetes range, below ≥126)
Isolated essential hypertension — ruled out by concurrent central obesity, low HDL, and hypertriglyceridemia
Familial/primary dyslipidemia — ruled out by clustering with multiple metabolic criteria rather than an isolated lipid disorder
Cushing syndrome — ruled out by absence of cortisol-excess physical stigmata
Hypothyroidism — ruled out by absence of hypothyroid symptoms; check TSH if suspected

Key Distinguishing Test

Metabolic syndrome is a clinical diagnosis requiring ≥3 of 5 criteria: waist circumference >40 inches (men)/>35 inches (women), triglycerides ≥150 mg/dL, HDL <40 mg/dL (men)/<50 mg/dL (women), BP ≥130/85 mm Hg, and fasting glucose ≥100 mg/dL. A fasting lipid panel, fasting glucose (or HbA1c), blood pressure, and waist circumference confirm it; Phineas meets all five.

Board Note

Metabolic syndrome roughly doubles cardiovascular disease risk and increases type 2 diabetes risk about 5-fold
Insulin resistance is the central underlying mechanism, linking central adiposity to dyslipidemia, hypertension, and dysglycemia
First-line therapy is lifestyle modification: ≥150 min/week of moderate activity, a Mediterranean or similar dietary pattern, and 5%–10% weight loss
Manage each component to target — statin for ASCVD risk, antihypertensives, and glycemic prevention — rather than treating the "syndrome" as a single entity
Consider metformin for diabetes prevention in higher-risk prediabetes: age <60, BMI ≥35, fasting glucose ≥110 mg/dL, HbA1c ≥6.0%, or prior gestational diabetes
Screen for associated conditions such as metabolic dysfunction–associated steatotic liver disease and obstructive sleep apnea

“Phineas’s Story”